Lewis Sanders
Sanders Capital
Sanders Capital Portfolio 13F
Lewis Sanders Holdings Activity
- Portfolio value:
- $8.98B≈ (+$369M≈)
- Previous value:
- $8.61B≈
- # of changes:
- 46
- New positions:
- 1
- Reported for:
- 30 Jun 2014 (Q2)
- Latest filing date:
- 07 Sep 2022
Sanders Capital has disclosed a total of 46 changes to the portfolio in the (2014 Q2) SEC report(s): increased the number of shares of 35, bought 1 totally new, decreased the number of shares of 8 and completely sold out 2 position(s).
What stocks did Lewis Sanders buy in 2014 Q2?
During 2014 Q2 Lewis Sanders has bought 36 securities out of which top 5 purchases (by % change to portfolio) were (AAPL) Apple Inc (added shares +47.14%), (INTC) Intel Corp (added shares +1.77%), (C) Citigroup Inc (added shares +17.24%), (MSFT) Microsoft Corp (added shares +1.56%) and (JPM) JPMorgan Chase & Co (added shares +20.94%).
In the 2014 Q2 report(s) the following changes have been made to the top investments: (AAPL) Apple Inc (added shares +47.14%), (INTC) Intel Corp (added shares +1.77%), (C) Citigroup Inc (added shares +17.24%), (MSFT) Microsoft Corp (added shares +1.56%) and (JPM) JPMorgan Chase & Co (added shares +20.94%).
46 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fifth Third Bancorp
|
new
|
$21.35
|
+173.39%($58.37)
|
0.05%
|
2014 Q2
|
≈ 0.25 years
|
||||
|
|
GlaxoSmithKline PLC ADR
|
+1,100.00%
|
$66.85
|
-22.79%($51.62)
|
0.02%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Vanguard FTSE All-World ex-US Index Fund ETF Shares
|
+70.64%
|
$52.29
|
+61.66%($84.54)
|
0.44%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Apple Inc
|
+47.14%
|
$23.23
|
+1,233.43%($309.79)
|
6.26%
|
2013 Q3
|
≈ 1.00 year
|
||||
|
|
JPMorgan Chase & Co
|
+20.94%
|
$57.62
|
+525.42%($360.36)
|
5.12%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
Citigroup Inc
|
+17.24%
|
$47.10
|
+190.79%($136.96)
|
5.69%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
RYLAND GROUP INC/THE
|
+13.22%
|
$39.44
|
|
1.11%
|
2013 Q4
|
≈ 0.75 years
|
||||
|
|
Aetna Inc
|
+12.88%
|
$81.08
|
|
2.38%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
|
|
DR Horton Inc
|
+12.14%
|
$24.58
|
+509.40%($149.79)
|
2.62%
|
2013 Q4
|
≈ 0.75 years
|
||||
|
|
Barclays PLC ADR
|
+11.98%
|
$14.61
|
+93.01%($28.20)
|
0.05%
|
2013 Q2 or earlier
|
≈ 1.25+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.